{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:52:37Z","timestamp":1791503557057,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program","award":["2023YFC2307500"],"award-info":[{"award-number":["2023YFC2307500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28412-y","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:24:22Z","timestamp":1784100262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatiotemporal epidemiology of hepatitis B in Central China: urbanization drivers and implications for adult-targeted control strategies"],"prefix":"10.1186","volume":"26","author":[{"given":"Yanquan","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"3","key":"28412_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/vaccines12030288","volume":"12","author":"SA Al-Busafi","year":"2024","unstructured":"Al-Busafi SA, Alwassief A. Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030. Vaccines. 2024;12(3):288.","journal-title":"Vaccines"},{"issue":"12","key":"28412_CR2","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1136\/gutjnl-2023-330691","volume":"72","author":"Z Liu","year":"2023","unstructured":"Liu Z, Lin C, Mao X, Guo C, Suo C, Zhu D, et al. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people. Gut. 2023;72(12):2354\u201363.","journal-title":"Gut"},{"key":"28412_CR3","doi-asserted-by":"crossref","unstructured":"Liao X, Liang Z: Strategy vaccination against Hepatitis B in China. Human Vaccines & Immunotherapeutics. 2015;11(6):1534\u20139.","DOI":"10.1080\/21645515.2015.1009337"},{"key":"28412_CR4","doi-asserted-by":"crossref","unstructured":"Bai S, Dang W, Hong W, Liao W, Smith RD: The prevalence of hepatitis B in Chinese general population from 2018 to 2022: a systematic review and meta-analysis. BMC Infect Dis 2024;24(1):211.","DOI":"10.1186\/s12879-024-09103-8"},{"key":"28412_CR5","doi-asserted-by":"crossref","unstructured":"Sun N, He F, Sun J, Zhu G: Viral hepatitis in China during 2002\u20132021: epidemiology and influence factors through a country-level modeling study. BMC Public Health 2024;24(1):1820.","DOI":"10.1186\/s12889-024-19318-8"},{"issue":"4","key":"28412_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","volume":"8","author":"F Cui","year":"2023","unstructured":"Cui F, Blach S, Manzengo Mingiedi C, Gonzalez MA, Sabry Alaama A, Mozalevskis A, et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 2023;8(4):332\u201342.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"28412_CR7","doi-asserted-by":"crossref","unstructured":"Liu Z, Li M, Hutton DW, Wagner AL, Yao Y, Zhu W, Cao L, Tang S, Pan J, Wang Y et al: Impact of the national hepatitis B immunization program in China: a modeling study. Infect Dis Poverty. 2022;11(1):106.","DOI":"10.1186\/s40249-022-01032-5"},{"issue":"1","key":"28412_CR8","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1186\/s12879-025-12015-w","volume":"25","author":"M Sun","year":"2025","unstructured":"Sun M, Chen X, Chen Y, Zhang X. Mother-to-child transmission of hepatitis B virus, its associated risk factors, and the adoption of maternal antiviral therapy in eastern China: a retrospective cohort study. BMC Infect Dis. 2025;25(1):1642.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"28412_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1186\/s12889-022-13594-y","volume":"22","author":"W Liu","year":"2022","unstructured":"Liu W, Zhuang T, Xia R, Zou Z, Zhang L, Shen M, et al. Modelling the prevalence of hepatitis B towards eliminating it as a major public health threat in China. BMC Public Health. 2022;22(1):1179.","journal-title":"BMC Public Health"},{"issue":"1","key":"28412_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12879-023-08911-8","volume":"24","author":"N Yao","year":"2024","unstructured":"Yao N, Liu Y, Xu J, Wang Q, Zhou Q, Wang Y, et al. Identification of associated risk factors for serological distribution of hepatitis B virus via machine learning models. BMC Infect Dis. 2024;24(1):66.","journal-title":"BMC Infect Dis"},{"key":"28412_CR11","doi-asserted-by":"crossref","unstructured":"Liao H, Li Y, Li Y, Huang S, Gao C, Kong J, Liu Q, Xia J: Risk of coimmunisation of hepatitis B-exposed children with unprotective antibodies based on machine learning algorithms. Res Square 2024.Research Square [Preprint]. 2024.","DOI":"10.21203\/rs.3.rs-4943031\/v1"},{"key":"28412_CR12","volume-title":"Hubei statistical yearbook 2024","author":"Hubei Provincial Bureau of Statistics","year":"2024","unstructured":"Hubei Provincial Bureau of Statistics. Hubei statistical yearbook 2024. Beijing: China Statistics Press; 2024."},{"key":"28412_CR13","doi-asserted-by":"crossref","unstructured":"Nduwayezu G, Zhao P, Kagoyire C, Eklund L, Bizimana JP, Pilesjo P, Mansourian A: Understanding the spatial non-stationarity in the relationships between malaria incidence and environmental risk factors using geographically weighted random forest: a case study in Rwanda. Geospatial Health. 2023;18(1):1184.","DOI":"10.4081\/gh.2023.1184"},{"issue":"1","key":"28412_CR14","doi-asserted-by":"publisher","first-page":"21141","DOI":"10.1038\/s41598-024-72047-1","volume":"14","author":"S Pei","year":"2024","unstructured":"Pei S, Yang L, Gao H, Liu Y, Dai E, Feng F, et al. Pollutants-mediated viral hepatitis in different types: assessment of different algorithms and time series models. Sci Rep. 2024;14(1):21141.","journal-title":"Sci Rep"},{"key":"28412_CR15","unstructured":"Ministry of Health of the People's Republic of China: Diagnostic criteria for viral hepatitis B: WS 299\u20132008. Beijing: People\u2019s Medical Publishing House; 2009."},{"key":"28412_CR16","unstructured":"World Health Organization: Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. 2024."},{"issue":"1","key":"28412_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, et al. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2(1):56\u201367.","journal-title":"Nat Mach Intell"},{"issue":"4","key":"28412_CR18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.ijforecast.2010.11.002","volume":"27","author":"M Theodosiou","year":"2011","unstructured":"Theodosiou M. Forecasting monthly and quarterly time series using STL decomposition. Int J Forecast. 2011;27(4):1178\u201395.","journal-title":"Int J Forecast"},{"issue":"6","key":"28412_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s12072-022-10400-0","volume":"16","author":"H Zheng","year":"2022","unstructured":"Zheng H, Walsh N, Lesi O, Cui F. New progress towards elimination of mother-to-child transmission of hepatitis B virus in China. Hepatol Int. 2022;16(6):1273\u201381.","journal-title":"Hepatol Int"},{"issue":"1","key":"28412_CR20","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1186\/s12889-025-22452-6","volume":"25","author":"K Fang","year":"2025","unstructured":"Fang K, Cheng N, Nie C, Song W, Zhao Y, Pan J, et al. Spatial and temporal distribution patterns and factors influencing hepatitis B in China: a geo-epidemiological study. BMC Public Health. 2025;25(1):1276.","journal-title":"BMC Public Health"},{"issue":"1","key":"28412_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12889-023-17587-3","volume":"24","author":"C-Q He","year":"2024","unstructured":"He C-Q, Sun B-H, Yu W-T, An S-Y, Qiao B-J, Wu W. Evaluating the impact of COVID-19 outbreak on hepatitis B and forecasting the epidemiological trend in mainland China: a causal analysis. BMC Public Health. 2024;24(1):47.","journal-title":"BMC Public Health"},{"issue":"3","key":"28412_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ajic.2024.10.010","volume":"53","author":"J Li","year":"2025","unstructured":"Li J, Yuan F, Fan S, Tian J, Yang J. The impact of COVID-19 pandemic on reported notifiable infectious diseases in China: an interrupted time series analysis. Am J Infect Control. 2025;53(3):340\u20137.","journal-title":"Am J Infect Control"},{"key":"28412_CR23","doi-asserted-by":"crossref","unstructured":"Yu Y, Shen L: Changes in the incidence of notifiable infectious diseases before, during, and after the COVID-19 pandemic in Mainland China. BMC Infect Dis. 2026;26(1).","DOI":"10.1186\/s12879-025-12275-6"},{"key":"28412_CR24","doi-asserted-by":"crossref","unstructured":"Li Q, Zhao X, Meng H, Zhang Q, Liu X, Jiang X, Qi X: Analysis of reported incidence of chronic hepatitis B in Chaoyang District, Beijing during 2005\u20132022 with age-period-cohort model. Front Public Health. 2025;13:1486475.","DOI":"10.3389\/fpubh.2025.1486475"},{"issue":"1","key":"28412_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-024-09716-z","volume":"24","author":"L Jiao","year":"2006","unstructured":"Jiao L, Shen T, Han Y, Liu W, Liu W, Dang L, et al. The spatial-temporal distribution of hepatitis B virus infection in China,2006-2018. BMC Infect Dis. 2006;24(1):811.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"28412_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40249-023-01163-3","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu X, Sun Y, Yin Y, Dai X, Bergquist R, Gao F, et al. Influence of urbanization on schistosomiasis infection risk in Anhui Province based on sixteen year\u2019s longitudinal surveillance data: a spatio-temporal modelling study. Infect Dis Poverty. 2023;12(1):108.","journal-title":"Infect Dis Poverty"},{"issue":"4","key":"28412_CR27","doi-asserted-by":"publisher","first-page":"e1004374","DOI":"10.1371\/journal.pmed.1004374","volume":"21","author":"L Chen","year":"2013","unstructured":"Chen L, Xing Y, Zhang Y, Xie J, Su B, Jiang J, et al. Long-term variations of urban-rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: an observational study. PLoS Med. 2013;21(4):e1004374.","journal-title":"PLoS Med"},{"issue":"5","key":"28412_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/21645515.2015.1123358","volume":"12","author":"R Liu","year":"2016","unstructured":"Liu R, Li Y, Wangen KR, Maitland E, Nicholas S, Wang J. Analysis of hepatitis B vaccination behavior and vaccination willingness among migrant workers from rural China based on protection motivation theory. Hum Vaccin Immunother. 2016;12(5):1155\u201363.","journal-title":"Hum Vaccin Immunother"},{"key":"28412_CR29","doi-asserted-by":"crossref","unstructured":"Yu D, Li X, Yu J, Shi X, Liu P, Tian P: Whether urbanization has intensified the spread of infectious diseases\u2014renewed question by the COVID-19 Pandemic. Front Public Health. 2021;9:699710.","DOI":"10.3389\/fpubh.2021.699710"},{"issue":"1","key":"28412_CR30","doi-asserted-by":"publisher","first-page":"19845","DOI":"10.1038\/s41598-023-45672-5","volume":"13","author":"J Li","year":"2000","unstructured":"Li J, Xu Z, Zhu H. Spatial\u2013temporal analysis and spatial drivers of hepatitis-related deaths in 183 countries, 2000\u20132019. Sci Rep. 2000;13(1):19845.","journal-title":"Sci Rep"},{"key":"28412_CR31","doi-asserted-by":"crossref","unstructured":"Zou X, Chow EPF, Zhao P, Xu Y, Ling L, Zhang L: Rural-to-urban migrants are at high risk of sexually transmitted and viral hepatitis infections in China: a systematic review and meta-analysis. BMC Infect Dis. 2014;14(1):490.","DOI":"10.1186\/1471-2334-14-490"},{"issue":"1","key":"28412_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12879-022-07669-9","volume":"22","author":"J Zheng","year":"2022","unstructured":"Zheng J, Shen G, Hu S, Han X, Zhu S, Liu J, et al. Small-scale spatiotemporal epidemiology of notifiable infectious diseases in China: a systematic review. BMC Infect Dis. 2022;22(1):723.","journal-title":"BMC Infect Dis"},{"key":"28412_CR33","doi-asserted-by":"crossref","unstructured":"Akingbola A, Faniyi O, Adewole O, Otumara JU: Narrative review of conflict and non-conflict influences on hepatitis B prevalence in Sub-Saharan Africa using the socio-ecological model. Discov Public Health. 2025;22(1):414.","DOI":"10.1186\/s12982-025-00776-3"},{"issue":"1","key":"28412_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12889-025-21668-w","volume":"25","author":"JM Gizamba","year":"2025","unstructured":"Gizamba JM, Finch BK, Wang S, Klausner JD. Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses. BMC Public Health. 2025;25(1):687.","journal-title":"BMC Public Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28412-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28412-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28412-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:37:47Z","timestamp":1791502667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28412-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28412"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28412-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and relevant guidelines and regulations. The study was exempt from ethics review as it used deidentified surveillance data from the statutory infectious disease surveillance system without direct patient involvement. All data were obtained from the Hubei Provincial surveillance system with personal identifiers removed.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2897"}}